All Type of News
There are some pharmaceutical policies vary in 2014
What pharmaceutical policies would vary in 2014?
By 2016, the Ministry of Health and Welfare plans to apply health insurance to all essential medical services for the treatment of 'four main severe diseases', whic...
National Assembly passed a powerful bill, 'deletion of insurance reimbursement' to medicines related
National Assembly passed a powerful bill, 'deletion of insurance reimbursement' to medicines related in illegal kickbacks.
It seems that the nightmare of pharmaceutical industry about illegal kickbacks is not over ...
Some multinational pharmaceutical companies are reviewing to acknowledge the financial costs
It is known that there is a subtle opinion gap between multinational pharmaceutical companies to the demand of pharmaceutical wholesale industry who requires improving low-margin business policies.
In the past yea...
The price of 'Novorapid injection(Novorapid)' was reduced
From Jan 1, Novo Nordisk Pharma Korea cut down the price of its ultra rapid acting insulin 'Novorapid injection(Novorapid)' 100 IU/ml by 6.6%.
Starting from year 2014, the medicine price reduces from 23,288 won to...
On Jan 5, there will be a resolution meeting with the chairmans of pharmaceutical associations in en
On Jan 5, there will be a resolution meeting with the chairmans of pharmaceutical associations in entire country.
On Jan 2, Korean Pharmaceutical association held its first new year meeting with the chairmans of ph...
Over the past year, stock prices of listed pharmaceutical companies climbed 2.8 percent on average
(Yakup shinmoon)
Over the past year, stock prices of listed pharmaceutical companies climbed 2.8 percent on average and market capitalization increased by more than 400 billion won.
Yuhan Corporation's market c...
For the anti-cancer drug development, 9.4 billion won is invested by the MOHW this year
(Yakup Shinmoon)
This year for the anti-cancer drug development, about 9 billion won is invested. A budget of 200 million won was organized for the overseas expansion of the health industry.
On Jan 1, National ...
The MFDS promulgated introduction of 'risk-sharing' and amendment of 'price-volume agreement'
(Yakup Shinmoon)
The price of Boehringer Ingelheim 'Twinsta' and other large items are decreased by up to 10% due to increase in drug usage.
The Ministry of Health and Welfare said that on Dec 31, amendment of ...
Pharmaceutical companies demand necessity of research group
(Yakup Shinmoon)
“Market based Actual Transaction Price(ATP)” is going to be implemented again in February of this year, bringing the order that research groups should be activated.
Since different interests of...
CJ CheilJedang Corp. released incrementally modified drug complex for diabetes 'Vogmat'
(Yakup Shinmoon)
CJ CheilJedang Corp. released incrementally modified drug complex for diabetes 'Vogmat' (voglibose + metformin).
In June last year, Vogmet was permitted for the first time as a dosage form whic...
